An Unusual Presentation of Malignant Pleural Mesothelioma

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Next Generation Sequencing Uncovers Potential Genetic Driver Mutations of Malignant Pulmonary Granular Cell Tumor  Song Xu, Qingchun Zhao, Sen Wei, Yi.
Pulmonary Alveolar Proteinosis, Barbecue Smoke, and Granulocyte-macrophage Colony-stimulating Factor Therapy  Gaja F. Shaughnessy, MD, Augustine S. Lee,
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Lungs on Fire Journal of Thoracic Oncology
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
EGFR and KRAS Mutations in Triple-Mutated Lung Cancer
Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 
Localized Malignant Pleural Mesothelioma: Report of Two Cases
A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,
Pleural Fluid Cytological Yield and Visceral Pleural Invasion in Patients with Epithelioid Malignant Pleural Mesothelioma  Valentina Pinelli, MD, Sophie.
Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Pleural Well-Differentiated Papillary Mesothelioma: A Case Report
KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.
Treatment of Pulmonary Epithelioid Hemangioendothelioma with Bevacizumab  Young Hak Kim, MD, Michiaki Mishima, MD, PhD, Aya Miyagawa-Hayashino, MD, PhD 
Electronic Updates for JTO Readers
Ground glass opacity of the lung: The veil that needs lifting
Miliary Mesothelioma: A New Clinical and Radiological Presentation in Mesothelioma Patients with Prolonged Survival After Trimodality Therapy  Lesek Purek,
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First- line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor.
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Hepatoid Carcinoma of the Lung with Anaplastic Lymphoma Kinase Gene Rearrangement  Sean Khozin, MD, Mark J. Roth, MD, Arun Rajan, MD, Karen Smith, MD,
A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib  Akihiro Tamiya,
Surgical Treatment of a Giant Symptomatic Cardiac Lipoma
Lung Metastases from Esophageal Granular Cell Tumor: An Undoubted Criterion for Malignancy  Isidro Machado, MD, PhD, Julia Cruz, MD, PhD, Estanislao Arana,
Ritbune Prakobkit, MD, William Churk-Nam Auyeung, MD 
Elizabeth B. Gottlin, PhD, Rex C. Bentley, MD, Michael J
Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib  Shiro Fujita, MD, PhD, Katsuhiro Masago, MD, PhD, Nobuyuki Katakami, MD, PhD,
Volume 153, Issue 6, Pages e153-e157 (June 2018)
Primary Malignant Pericardial Mesothelioma Mimicking Pericardial Metastasis from Adenocarcinoma  Masafumi Horie, MD, Satoshi Noguchi, MD, Wakae Tanaka,
A Case of Pleural Epithelioid Sarcoma of Proximal Type Presenting as Malignant Pleural Mesothelioma  Gitte Anna Madsen, MD, Torben Riis Rasmussen, MD,
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
Non–Small-Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment  Gerald S. Falchook, MD,
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Vamsidhar Velcheti, MD  Journal of Thoracic Oncology 
Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers  Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma  Naoyuki.
EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer  Allison Ackerman, MD, Michael A. Goldstein,
Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer  Hong Kwan Kim, MD, Yong Soo Choi,
Nivolumab-Induced Granulomatous Inflammation of the Pleura
A Case of Pemetrexed-Induced Acute Lung Injury in Non-small Cell Lung Cancer  Hye Ok Kim, MD, Sung Yong Lee, MD, PhD, Jae Jeong Shim, MD, PhD, Kyung Ho.
Spontaneous Pneumothorax and Lung Carcinoma: Should One Consider Synchronous Malignant Pleural Mesothelioma?  Trevor A. Flood, MD, Harman S. Sekhon, MD,
Shih-Chieh Chang, Cheng-Yu Chang, Chiung-Yu Chen, Chong-Jen Yu 
A Rare Subglottic Capillary Hemangioma
Multiple Pulmonary Nodules in an Elderly Woman
Atypical Primary Epithelioid Hemangioendothelioma of the Heart
Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer  Hiroaki Ogata,
A Rare Case of Endobronchial Amelanotic Melanoma
Two Generations of Light/Never-Smokers With Advanced Adenocarcinoma of the Lung with Durable Responses to Erlotinib  Nathan A. Pennell, MD, PhD, Lihong.
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Antiangiogenesis Induced Tumor Cavitation in Lung Cancer
EGFR Mutations in Squamous Cell Lung Cancer in Never-Smokers
European Lung Cancer Conference (ELCC) 2016 Organisation
Tetsuzo Tagawa, MD, Miyuki Takasu, MD, Teruyoshi Ishida, MD 
Nonintubated thoracoscopic surgery for pulmonary lesions in both lungs
A Pathological Complete Response in Malignant Pleural Mesothelioma after Combination Chemotherapy with Carboplatin and Pemetrexed  Steven Chuan-Hao Kao,
Pleural Metastases of Malignant Melanoma
Journal of Thoracic Oncology
Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer
Successful Treatment with Pemetrexed in a Patient with Mucinous Bronchioloalveolar Carcinoma: Long-Term Response Duration with Mild Toxicity  Chiyuki.
A B3 Type-Thymoma in a 7-Year-Old Child with Myasthenia Gravis
Debby P. M. van den Bogaert, MD, Ellen M
A Review of First-Line Treatment for Small-cell Lung Cancer
Presentation transcript:

An Unusual Presentation of Malignant Pleural Mesothelioma Miangela M. Lacle, MD, Matthijs F.M. van Oosterhout, MD, PhD  Journal of Thoracic Oncology  Volume 8, Issue 7, Pages e63-e64 (July 2013) DOI: 10.1097/JTO.0b013e318286c1a5 Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 High-resolution computed tomography showing peripheral increase in the vascular markings, septal thickening, diffuse nodular opacities in both lungs, and ground-glass opacities in the left lung. Journal of Thoracic Oncology 2013 8, e63-e64DOI: (10.1097/JTO.0b013e318286c1a5) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 High-powered micrograph showing epithelioid cells (hematoxylin and eosin staining). High-powered micrograph showing positive cytoplasmic and nuclear staining for calretinin and positive staining for CK5/6 (calretinin staining and CK5/6 staining). Journal of Thoracic Oncology 2013 8, e63-e64DOI: (10.1097/JTO.0b013e318286c1a5) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions